SESN Sesen Bio Inc

Eleven Biotherapeutics Inc is a biotechnology-based firm in the United States. It is engaged in the development of therapeutics to cure diseases related to the eye.

As of 10/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/06/2014
Outstanding shares:  196,002,620
Average volume:  25,912,452
Market cap:   $225,403,013
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    817763105
ISIN:        US8177631053
Valuation   (See tab for details)
PE ratio:   -2.24
PB ratio:   4.58
PS ratio:   12.68
Return on equity:   -240.27%
Net income %:   -666.88%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy